Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant
- Status
- TERMINATED
- Phase
- PHASE2
NK Cells in Cord Blood Transplantation
- Status
- UNKNOWN
- Phase
- PHASE1
Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL Pilot
- Status
- TERMINATED
- Phase
- NA
Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR
- Status
- COMPLETED
- Phase
- NA
INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE3
Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor
- Status
- TERMINATED
- Phase
- NA
Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2
Human Placental-Derived Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Oral Rigosertib in Transfusion-dependent, Low or Int-1 or Trisomy 8 Int-2 Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning
- Status
- COMPLETED
- Phase
- PHASE2
The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE3
The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).
- Status
- UNKNOWN
- Phase
- PHASE2
TevaGastrim for Stem Cell Mobilization Sibling Donors
- Status
- COMPLETED
- Phase
- PHASE2
VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study Comparing Siltuximab Plus Best Supportive Care to Placebo Plus Best Supportive Care in Anemic Patients With International Prognostic Scoring System Low- or Intermediate-1-Risk Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE2